Data Supplement
- Supplemental Figures -
Supplementary Figure 1 - Association of SLCO1B1 genotyped-predicted phenotype with bilirubin levels before and after efavirenz treatment.
Supplementary Figure 2 - Multiple dosing efavirenz effect on bilirubin levels by SLCO1B1 genotype-predicted phenotype.
Supplementary Figure 3 - Multiple dosing efavirenz effect on total bilirubin levels by SLCO1B1 genotype-predicted phenotype among UGT1A1 normal metabolizers only.